History
- 1984: The first active specific immunotherapy with antigen amplified tumor lysates in patients with ovarian cancer was in the center for women’s health at the University Hospital Göttingen (Dr. T. Neßelhut)
- 1987: The first description of monocyte derived antigen presenting (Prof. Dr. J. H. Peters)
- 1992: Founding of the practice Neßelhut with an oncologic focus and treatment of patients with active specific immunotherapy in Duderstadt (Dr. T. Neßelhut)
- 1996: Founding of the institute for tumor therapy (Dr. T. Neßelhut)
- 1999: Treatment of gynecological-oncological patients with dendritic cells at the University Hospital Göttingen (Dr. K. Neßelhut)
Founding of the DC Gesellschaft für Dendritic-cell-Therapie mbH, start of oncologic treatment with dendritic cells in Duderstadt (Prof. Dr. J. H. Peters, Dr. T. Neßelhut) - 2000 - 2006: Manufacturing permission for active specific immunotherapies (Dr. T. Neßelhut)
- 2004: Dr. J. Neßelhut joined the practice Neßelhut
- 2008: Founding of the Group Practice for Cell Therapy (Praxisgemeinschaft für Zelltherapie Duderstadt GmbH & Co. KG) (Dr. T. Neßelhut, Dr. J. Neßelhut)
- 2009: Dr. Dr. M. Martin, Dr. K. Briken and Dr. W.-P. Brockmann joined the Joint Practice Group
- 2005 - 2010: Funding of research projects by the Society for Biological Cancer defense (Gesellschaft für biologische Krebsabwehr), the research center Jülich and
with means from the European fund for regional development of Lower Saxony
- 2010: Dr. K. Neßelhut joined the practice and group practice for cell therapy
- 2011: Opening of new laboratory facilities in Duderstadt
- 2012: Manufacturing license for somatic cell therapeutics granted